|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 4/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
164,320,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $0.6539 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ViewRay designs, manufactures and markets the ViewRay MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary magnetic resonance imaging (MRI) system to address the challenges and clinical workflow for radiation oncology. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic-quality MRI with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. Co.'s generations of the MRIdian are: the MRIdian with Cobalt-60 based radiation beams and MRIdian Linac, with linear accelerator or linac based radiation beams.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
55,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$204,826 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
13,487,227 |
13,529,227 |
| Total Sell Value |
$0 |
$0 |
$844,275 |
$1,017,735 |
| Total People Sold |
0 |
0 |
8 |
9 |
| Total Sell Transactions |
0 |
0 |
11 |
12 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bansal Ajay |
Chief Financial Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,661 |
90,765 |
|
- |
|
| Alecxih James |
Chief Commercial Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,371 |
38,371 |
|
- |
|
| Dempsey James F. |
Chief Scientific Officer |
• • – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,371 |
220,973 |
|
- |
|
| Moore Daniel Jeffrey |
Director |
– • – |
2019-01-02 |
4 |
A |
$6.16 |
$89,998 |
D/D |
14,610 |
33,278 |
|
- |
|
| Huennekens R Scott |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$59,998 |
D/D |
28,408 |
34,211 |
|
- |
|
| Moore Daniel Jeffrey |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,668 |
18,668 |
|
- |
|
| Wang Theodore T |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$44,999 |
D/D |
25,973 |
34,117 |
|
- |
|
| Mckinnell Henry A |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$54,996 |
D/D |
27,596 |
689,046 |
|
- |
|
| Castelein Caley |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$61,994 |
D/D |
28,732 |
706,630 |
|
- |
|
| Roberts Brian K |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,668 |
46,543 |
|
- |
|
| Puri Aditya |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$61,994 |
D/D |
28,732 |
61,553 |
|
- |
|
| Grossman D Keith |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$54,996 |
I/I |
27,596 |
27,596 |
|
- |
|
| Matin Shahriar |
Chief Operating Officer |
• – – |
2018-11-13 |
4 |
B |
$6.47 |
$161,750 |
D/D |
25,000 |
602,500 |
2.74 |
- |
|
| Drake Scott William |
President & CEO |
• • – |
2018-11-13 |
4 |
B |
$6.47 |
$388,200 |
D/D |
60,000 |
1,215,000 |
2.81 |
- |
|
| Fosun International Ltd |
10% Owner |
– – • |
2018-08-30 |
4 |
B |
$9.25 |
$24,999,994 |
D/D |
2,702,702 |
2,813,834 |
2.45 |
- |
|
| Orbimed Capital Gp Iii Llc |
10% Owner |
– – • |
2018-08-20 |
4/A |
S |
$9.98 |
$3,072,263 |
I/I |
(307,842) |
68,898 |
|
- |
|
| Orbimed Capital Gp Iii Llc |
10% Owner |
– – • |
2018-08-20 |
4 |
S |
$9.98 |
$1,550,762 |
I/I |
(155,387) |
69,617 |
|
- |
|
| Castelein Caley |
Director |
– • – |
2018-08-17 |
4 |
A |
$9.98 |
$5,099,071 |
D/D |
510,929 |
677,898 |
|
- |
|
| Orbimed Capital Gp Iii Llc |
10% Owner |
– – • |
2018-08-16 |
4/A |
S |
$9.94 |
$3,640,227 |
I/I |
(366,220) |
70,364 |
|
- |
|
| Orbimed Capital Gp Iii Llc |
10% Owner |
– – • |
2018-08-16 |
4 |
S |
$9.94 |
$3,640,227 |
I/I |
(366,220) |
71,083 |
|
- |
|
| Orbimed Capital Gp Iii Llc |
10% Owner |
– – • |
2018-08-15 |
4/A |
S |
$9.93 |
$775,037 |
I/I |
(78,050) |
73,819 |
|
- |
|
| Orbimed Capital Gp Iii Llc |
10% Owner |
– – • |
2018-08-15 |
4 |
S |
$9.93 |
$775,037 |
I/I |
(78,050) |
74,538 |
|
- |
|
| Orbimed Capital Gp Iii Llc |
10% Owner |
– – • |
2018-08-14 |
4/A |
S |
$9.94 |
$208,492 |
I/I |
(20,975) |
74,555 |
|
- |
|
| Orbimed Capital Gp Iii Llc |
10% Owner |
– – • |
2018-08-14 |
4 |
S |
$9.94 |
$208,492 |
I/I |
(20,975) |
75,274 |
|
- |
|
| Orbimed Capital Gp Iii Llc |
10% Owner |
– – • |
2018-08-13 |
4/A |
S |
$9.98 |
$867,492 |
I/I |
(86,923) |
74,753 |
|
- |
|
318 Records found
|
|
Page 9 of 13 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
